In which of the following conditions the level of creatinine kinase 1 increases?
The correct answer should be a condition affecting the brain. Let's look at possible options. Common conditions that cause elevated CK-BB include cerebral infarction, brain tumors, or head trauma. Maybe also subarachnoid hemorrhage. So if the options include any of these, that's the correct one.
Now, the incorrect options. CK-MM is elevated in muscle damage, like rhabdomyolysis or Duchenne's. CK-MB is elevated in MI. So if the options have muscle-related or heart-related conditions, those would be wrong. Also, conditions like liver disease or renal failure don't specifically elevate CK-BB. So the wrong options would be those related to other CK isoforms or unrelated conditions.
Clinical pearl: Remembering the CK isoforms and their sources is key. CK-MM is muscle, CK-MB is heart, CK-BB is brain. So CK-1 (CK-BB) increases in brain injury. A high-yield fact for exams is that CK-BB levels rise after cerebral infarction, especially in the first 24-48 hours, peaking around 24 hours. This can help differentiate between brain injury and other causes of CK elevation.
Wait, the user didn't list the options. But in the original question, the correct answer is likely a brain-related condition. So the correct answer's explanation should hinge on CK-BB being brain-specific. The wrong options would be muscle or heart conditions. Need to make sure the explanation clearly states that CK-1 is CK-BB and is elevated in brain injury, and the other CK types are from different sources.
**Core Concept**
Creatinine kinase 1 (CK-1), also known as CK-BB, is a brain-specific isoenzyme. Elevated CK-BB levels correlate with **central nervous system (CNS) injury**, such as cerebral infarction, subarachnoid hemorrhage, or traumatic brain injury. This contrasts with CK-MM (muscle) and CK-MB (heart) isoforms.
**Why the Correct Answer is Right**
CK-BB is predominantly expressed in **neurons and glial cells** of the brain. Acute CNS damage, like stroke or trauma, causes leakage of CK-BB into the bloodstream. Levels peak within **24β48 hours** post-injury and normalize over 72 hours. This makes CK-BB a **specific biomarker** for brain injury, distinct from muscle (CK-MM) or myocardial (CK-MB) damage.
**Why Each Wrong Option is Incorrect**
**Option A:** *Rhabdomyolysis* elevates **CK-MM**, not CK-BB.
**Option B:** *Myocardial infarction* increases **CK-MB**, not CK-BB.
**Option C